Clinical phenotypes of Korean patients with Behcet disease according to gender, age at onset, and HLA-B51
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background/Aims: The clinical manifestations of Behcet disease (BD) have been reported to differ according to country, region, and race. Gender, onset age, and human leukocyte antigen (HLA)-B51 have also been known as the factors that influence the clinical features of BD. The aim of this study is to investigate the clinical phenotypes of Korean patients who visited the rheumatology clinic with BD with respect to gender, onset age, and HLA-B51. Methods: Total 193 Korean patients (129 females and 64 males) fulfilling the international criteria for BD were retrospectively assessed. Results: The mean age at disease onset and disease duration of the BD patients were 32.2 ± 11.1 and 14.2 ± 9.3 years, retrospectively. Females suffered more frequently from genital ulcers (90.7% vs. 75.0%, p < 0.01), peripheral arthritis (67.4% vs. 43.8%, p < 0.01), and inf lammatory low back pain (38.8% vs. 23.4%, p = 0.03) than males, while skin involvement was more frequent in males than in females (90.6% vs. 75.2%, p = 0.01). The patients with late onset of BD (> 40 years) suffered from neurologic involvement (15.9% vs. 4.2%, p = 0.007) more frequently than those with early onset of BD. The patients with HLA-B51 showed earlier onset of disease than without HLA-B51 (28.3 ± 11.4 years vs. 33.8±11.6 years, p = 0.02) and the neurologic and gastrointestinal involvements were more frequent in the patients without HLA-B51 than with HLA-B51 (17.2% vs. 2.5%, p = 0.02 and 20.7% vs. 2.5%, p = 0.01, respectively). Conclusions: The clinical phenotypes in Korean patients with BD may be influenced by gender, onset age and HLA-B51.
Abstract
Background/Aims: The clinical manifestations of Behcet disease (BD) have been reported to differ according to country, region, and race. Gender, onset age, and human leukocyte antigen (HLA)-B51 have also been known as the factors that influence the clinical features of BD. The aim of this study is to investigate the clinical phenotypes of Korean patients who visited the rheumatology clinic with BD with respect to gender, onset age, and HLA-B51. Methods: Total 193 Korean patients (129 females and 64 males) fulfilling the international criteria for BD were retrospectively assessed. Results: The mean age at disease onset and disease duration of the BD patients were 32.2 ± 11.1 and 14.2 ± 9.3 years, retrospectively. Females suffered more frequently from genital ulcers (90.7% vs. 75.0%, p < 0.01), peripheral arthritis (67.4% vs. 43.8%, p < 0.01), and inf lammatory low back pain (38.8% vs. 23.4%, p = 0.03) than males, while skin involvement was more frequent in males than in females (90.6% vs. 75.2%, p = 0.01). The patients with late onset of BD (> 40 years) suffered from neurologic involvement (15.9% vs. 4.2%, p = 0.007) more frequently than those with early onset of BD. The patients with HLA-B51 showed earlier onset of disease than without HLA-B51 (28.3 ± 11.4 years vs. 33.8±11.6 years, p = 0.02) and the neurologic and gastrointestinal involvements were more frequent in the patients without HLA-B51 than with HLA-B51 (17.2% vs. 2.5%, p = 0.02 and 20.7% vs. 2.5%, p = 0.01, respectively). Conclusions: The clinical phenotypes in Korean patients with BD may be influenced by gender, onset age and HLA-B51.
참고문헌 (36)
- Davatchi F, "Behcet's disease", Acta Med Iran, 43, pp.233~242 (2005)
- Khairallah M, "Epidemiology of Behcet disease", Ocul Immunol Inflamm, 20, pp.324~335 (2012)[DOI]
- Kaklamani VG, "Behcet's disease", Semin Arthritis Rheum, 27, pp.197~217 (1998)[DOI]
- Onder M, "The multiple faces of Behcet's disease and its aetiological factors", J Eur Acad Dermatol Venereol, 15, pp.126~136 (2001)[DOI]
- Davatchi F, "Behcet's disease: from East to West", Clin Rheumatol, 29, pp.823~833 (2010)[DOI]
- Krause I, "Behcet's disease in Israel: the influence of ethnic origin on disease expression and severity", J Rheumatol, 28, pp.1033~1036 (2001)
- Rozenbaum M, "Behcet disease in adult Druzes in north Israel: the influence of ethnic origin on disease expression and severity", J Clin Rheumatol, 13, pp.124~127 (2007)[DOI]
- DongsikBang, "Influence of Sex on Patients with Behcet's Disease in Korea", Journal of Korean Medical Science, 18(2), pp.231~235 (2003), 대한의학회
- Yingbin Shang, "The Clinical Feature of Behçet’s Disease in Northeastern China", Yonsei Medical Journal, 50(5), pp.630~636 (2009), 연세대학교의과대학
- Davatchi F, "The influence of gender on the frequency of clinical symptoms in Behcet's disease", Adv Exp Med Biol, 528, pp.65~66 (2003)
- Tursen U, "Evaluation of clinical findings according to sex in 2313 Turkish patients with Behcet's disease", Int J Dermatol, 42, pp.346~351 (2003)[DOI]
- Zouboulis CC, "Onset signs, clinical course, prognosis, treatment and outcome of adult patients with Adamantiades-Behcet's disease in Greece", Clin Exp Rheumatol, 21(4 Suppl 30), pp.S19~S26 (2003)
- Saricaoglu H, "Clinical features of late-onset Behcet's disease: report of nine cases", Int J Dermatol, 45, pp.1284~1287 (2006)[DOI]
- Tsai J, "Late-onset Behcet's disease does not correlate with indolent clinical course: report of seven Taiwanese patients", J Eur Acad Dermatol Venereol, 22, pp.596~600 (2008)[DOI]
- Sungur G, "Late-onset Behcet's disease: demographic, clinical, and ocular features", Graefes Arch Clin Exp Ophthalmol, 248, pp.1325~1330 (2010)[DOI]
- Hazirolan D, "Demographic, clinical, and ocular features in patients with late-onset Behcet disease", Ocul Immunol Inflamm, 20, pp.119~124 (2012)[DOI]
- Alpsoy E, "Clinical features and natural course of Behcet's disease in 661 cases: a multicentre study", Br J Dermatol, 157, pp.901~906 (2007)[DOI]
- Hamuryudan V, "Prognosis of Behcet's syndrome among men with mucocutaneous involvement at disease onset: long-term outcome of patients enrolled in a controlled trial", Rheumatology (Oxford), 49, pp.173~177 (2010)[DOI]
- Hamzaoui A, "Comparison of clinical features of Behcet disease according to age in a Tunisian cohort", Acta Med Iran, 52, pp.748~751 (2014)
- Wallace GR, "HLA-B*51 the primary risk in Behcet disease", Proc Natl Acad Sci U S A, 111, pp.8706~8707 (2014)[DOI]
- Maldini C, "Relationships of HLA-B51 or B5 genotype with Behcet's disease clinical characteristics: systematic review and meta-analyses of observational studies", Rheumatology (Oxford), 51, pp.887~900 (2012)[DOI]
- Chang HK, "HLA-B51 and its allelic types in association with Behcet's disease and recurrent aphthous stomatitis in Korea", Clin Exp Rheumatol, 19(5 Suppl 24), pp.S31~S35 (2001)
- Hamzaoui A, "Contribution of Hla-B51 in the susceptibility and specific clinical features of Behcet's disease in Tunisian patients", Eur J Intern Med, 23, pp.347~349 (2012)[DOI]
- International Team for the Revision of the International Criteria for Behcet's Disease (ITR-ICBD), "The International Criteria for Behcet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria", J Eur Acad Dermatol Venereol, 28, pp.338~347 (2014)[DOI]
- Sieper J, "New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS)", Ann Rheum Dis, 68, pp.784~788 (2009)[DOI]
- Kalra S, "Diagnosis and management of Neuro-Behcet's disease: international consensus recommendations", J Neurol, 261, pp.1662~1676 (2014)[DOI]
- International Study Group for Behcet's Disease, "Criteria for diagnosis of Behcet's disease", Lancet, 335, pp.1078~1080 (1990)
- Behcet's Disease Research Committee of Japan, "Behcet's disease guide to the diagnosis of Behcet's disease (1972)", Jpn J Ophthalmol, 18, pp.291~294 (1974)
- Davatchi F, "Performance of existing diagnosis", classification criteria for Behcet's disease in Iranian patients: analysis of 5666 patients and 2406 controls, 2006, pp.9, 238~243
- Davatchi F, "Validation of the international criteria for Behcet's disease (ICBD) in Iran", Int J Rheum Dis, 13, pp.55~60 (2010)[DOI]
- Krause I, "Prevalence and clinical aspects of Behcet's disease in the north of Israel", Clin Rheumatol, 26, pp.555~560 (2007)[DOI]
- Kotevoglu N, "Coexistence of ankylosing spondylitis and Behcet's disease: two cases with atypical presentation and course", Scand J Rheumatol, 32, pp.184~185 (2003)[DOI]
- Cimen OB, "Behcet's syndrome coexisting with clinically occult ankylosing spondylitis", Z Rheumatol, 61, pp.440~442 (2002)[DOI]
- Yavuz S, "Activation of neutrophils by testosterone in Behcet's disease", Clin Exp Rheumatol, 25(4 Suppl 45), pp.S46~S51 (2007)
- Alpsoy E, "Androgen receptor levels of oral and genital ulcers and skin pathergy test in patients with Behcet's disease", Dermatology, 210, pp.31~35 (2005)[DOI]
- Atasoy M, "The relationship between serum prolactin levels and disease activity in patients with Behcet's disease", Cell Biochem Funct, 24, pp.353~356 (2006)[DOI]